Sources and their status
The Sources page lists every source, which are live in Atlas and which are planned, and when that list was last reviewed.
About PhaseFolio
A drug reaches patients through a long public record: trial registrations, regulatory decisions, company filings, publications. PhaseFolio connects that record so that anyone reading a comparison or a case can trace each value to its source.
The work
The facts behind a diligence question are public but scattered: a registry entry here, an approval there, a filing somewhere else, each in its own format and on its own schedule. PhaseFolio retrieves those records, keeps each value as the source recorded it, and marks what was not found or not searched instead of filling the gap.
Atlas compares trial records field by field. Workspace keeps the evidence, assumptions and scenarios of an asset case in one record. Sentinel is in development. None of them is clinical decision support: there is no treatment advice, no efficacy ranking and no verdict, only cited facts and the judgment of the people reading them.
The product family
Governance
The Sources page lists every source, which are live in Atlas and which are planned, and when that list was last reviewed.
The Workspace methodology records its sources, derivations and versioned assumptions, with a model card and a version history.
The security page describes tenancy, access, retention and the vendors that process data.
People
Founder and methodology author
MS Finance candidate at Johns Hopkins University and author of the PhaseFolio rNPV methodology, multi-indication backtest framework, model architecture, and clinical data pipeline.
LinkedInScientific and strategic advisor
Associate Research Professor in the Department of Health Policy and Management at Johns Hopkins Bloomberg School of Public Health, advising PhaseFolio on valuation methodology and benchmarking.
Get started